EU/South Korea trade deal includes pharma data protection and patent extensions
This article was originally published in Scrip
Executive Summary
The free trade agreement (FTA) initialled by the EU and South Korea last week formally recognises the importance of the World Trade Organization's 2001 TRIPS agreement on patent rights, which provides for the granting of drug compulsory licences in times of public health need.